Kilmax
Generic Name
Ciprofloxacin 250 mg tablet
Manufacturer
Hypothetical Pharma Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| kilmax 250 mg tablet | ৳ 25.00 | ৳ 200.00 |
Description
Overview of the medicine
Kilmax-250 mg tablet is a broad-spectrum antibiotic used to treat various bacterial infections, belonging to the fluoroquinolone class of drugs.
Uses & Indications
Dosage
Adults
The typical dosage ranges from 250 mg to 750 mg twice daily, depending on the severity and type of infection. For uncomplicated urinary tract infections, 250 mg twice daily for 3 days is often prescribed.
Elderly
Dosage adjustment may be necessary based on renal function and overall health status. Consult a physician for specific recommendations.
Renal_impairment
Reduced dosage is required. For creatinine clearance between 30-60 mL/min, administer 250-500 mg every 12 hours. For clearance <30 mL/min, administer 250-500 mg every 18-24 hours. Hemodialysis and CAPD patients should receive a dose after dialysis.
How to Take
Take Kilmax-250 mg tablet orally with a glass of water, preferably on an empty stomach or with meals. Avoid taking it with dairy products (milk, yogurt) or calcium-fortified juices. Do not crush or chew the tablet; swallow it whole. Ensure a 2-hour gap between taking Kilmax and consuming antacids containing aluminum or magnesium.
Mechanism of Action
Ciprofloxacin, the active ingredient, inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication, transcription, repair, and recombination, leading to bacterial cell death.
Pharmacokinetics
Onset
Within 1-2 hours
Excretion
Primarily renal (about 50-70% as unchanged drug) and to a lesser extent, fecal (15-30% as metabolites and unchanged drug).
Half life
Approximately 3-5 hours (in individuals with normal renal function)
Absorption
Rapidly and well absorbed from the gastrointestinal tract; bioavailability is approximately 70-80%. Peak plasma concentrations are reached 1-2 hours after oral administration.
Metabolism
Partially metabolized in the liver to four active metabolites (desethyleneciprofloxacin, sulfociprofloxacin, oxociprofloxacin, and formylciprofloxacin); however, primary excretion is renal.
Side Effects
Contraindications
- •Hypersensitivity to Ciprofloxacin or any other fluoroquinolone antibiotics.
- •Concomitant administration with Tizanidine (due to increased risk of adverse effects).
- •History of tendinitis or tendon rupture associated with fluoroquinolone use.
Drug Interactions
Caffeine
May decrease caffeine clearance and prolong its half-life, leading to increased caffeine effects.
Warfarin
May enhance the anticoagulant effect of warfarin, increasing the risk of bleeding. Close monitoring of INR (International Normalized Ratio) is recommended.
Cyclosporine
Increased serum creatinine has been observed. Close monitoring of renal function is advised.
Methotrexate
May increase methotrexate plasma concentrations, potentially leading to toxicity. Avoid co-administration if possible.
Theophylline
Ciprofloxacin can increase serum concentrations of theophylline, potentially leading to toxicity. Monitor theophylline levels and adjust its dosage if necessary.
Antacids (aluminum/magnesium), Sucralfate, Didanosine (chewable/buffered tablets)
These agents can significantly reduce the absorption of ciprofloxacin. Administer ciprofloxacin at least 2 hours before or 6 hours after these medications.
Storage
Store in a cool, dry place, below 30°C. Protect from direct light and moisture. Keep all medicines out of the reach and sight of children.
Overdose
In the event of an acute overdose, gastric emptying (e.g., induced vomiting or gastric lavage) should be performed. The patient should be carefully observed and given supportive treatment. Adequate hydration should be maintained. Hemodialysis or peritoneal dialysis remove only small amounts of ciprofloxacin from the body.
Pregnancy & Lactation
Kilmax (Ciprofloxacin) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as animal studies have shown potential adverse effects on cartilage development. Ciprofloxacin is excreted in breast milk and may cause adverse effects in a nursing infant (e.g., disruption of gut flora, potential for cartilage damage). Therefore, it should be used with caution in nursing mothers, and a decision to discontinue nursing or the drug should be made considering the importance of the drug to the mother.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
36 months from the date of manufacture when stored under recommended conditions.
Availability
Available in pharmacies nationwide
Approval Status
Approved by DGDA (Bangladesh)
Patent Status
Off-patent
WHO Essential Medicine
YesAlternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
More Medicines
Explore other medicines you might be interested in





